<DOC>
	<DOCNO>NCT02820493</DOCNO>
	<brief_summary>Anti-cytokine antibody , Infliximab ( anti TNF alfa chimeric antibody ) Adalimumab ( anti TNF alfa humanize antibody ) , develop use clinical practice treatment patient Crohn disease ( CD ) . Unfortunately , efficacy limit . Based concept , new drug develop IBD treatment . Vedolizumab ( VDZ ) able recognize α4β7 heterodimer , selectively block gut lymphocyte trafficking . The hypothesis study VDZ therapy may halt CD disease progression time modify natural history , use Lemann Index .</brief_summary>
	<brief_title>Effectiveness Vedolizumab CD Patients Naïve Anti-TNF</brief_title>
	<detailed_description>All patient enter study follow-up week 2-6-14-22-30-38-46 case relapse . A relapse define Harvey Bradshaw Index ≥ 5 2 consecutive week . The following data record : 1 . Physical examination 2 . Adverse Event Review 3 . Weight Kg 4 . Full blood count 5 . Biochemical series include serum iron , serum ferritin , C reactive protein ( PCR ) , ESR ( eritrosedimatation rate ) 6 . Fecal Calprotectin 7 . VDZ fecal loo 8 . VDZ trough level antidrug antibody 9 . Current treatments The last visit perform week 54 . The following data record : 1 . Physical examination 2 . Adverse Event Review 3 . Weight Kg 4 . Full blood count 5 . Biochemical series include serum iron , serum ferritin , C reactive protein ( PCR ) , ESR ( eritrosedimatation rate ) 6 . Fecal Calprotectin 7 . VDZ fecal loo 8 . VDZ trough level antidrug antibody 9 . Current treatment 10 . Routine low upper gastrointestinal endoscopy magnetic resonance imaging compute tomography small bowel 11 . SES-CD 12 . Lemann Index</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Vedolizumab</mesh_term>
	<criteria>Have give write informed consent participate Be age 18 80 Have moderate/severe CD define HBI &gt; 7 CD previous treatment antiTNF drug , concomitant use immunemodulator drug CD ( azathioprine/6mercaptopurine , methotrexate ) ulcerative colitis ( UC ) inflammatory bowel disease undetermined ( IBDU ) diagnosis symptomatic obstructive disease bowel resection within past 6 month ileostomy extensive small bowel resection ( determined investigator ) short bowel syndrome patient currently receive total parenteral nutrition history cancer past 5 year pregnancy know study inclusion positive Clostridium difficile stool assay Listeria , human immunodeficiency virus , central nervous system demyelinate disease , untreated tuberculosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>